Platform
Home
Screener
Copilot
AskEdgar Studio
New
Back
Novavax, Inc.
NVAX · SEC Filings
website
749
Novavax, Inc. is a biotechnology firm dedicated to discovering, developing, and commercializing vacc...
Price
10.89
Market Cap
1.8 B
Float
146.27 M
Country
US
Sector
Healthcare
Exchange
NASDAQ
Overview
Filings
Insights
Dilution
News
Transcripts
Search in Documents
Open in Studio
Studio
Login
Ask about NVAX
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
All
Chronological
Financials
Registrations
Prospectus
News
Proxies
Ownerships
Other
Novavax, Inc.
NVAX · SEC Filings
146.27 M
Float
10.89
Price
1.8 B
Market Cap
Financials
TYPE
HEADLINE
FILED AT
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 5, 2026
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 6, 2026
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 6, 2026
10-K
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 26, 2026
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 6, 2025
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 6, 2025
News
TYPE
HEADLINE
FILED AT
Prospectus
TYPE
HEADLINE
FILED AT
424B5
ATM | Offering Amount: $500,000,000 | Raisable Amount: $242,000,000
Aug 8, 2023
424B5
6,500,000 Shares
Dec 19, 2022
424B5
Registration
Dec 14, 2022
424B5
$500,000,000 of Common Stock-
Jun 15, 2021
424B5
$500,000,000 of Common Stock-
Jan 22, 2021
424B5
$500,000,000 of Common Stock
Nov 10, 2020
Registrations
TYPE
HEADLINE
FILED AT
S-8
Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 6, 2026
S-8
Registration
Aug 8, 2024
S-8
Registration
Aug 8, 2023
S-3ASR
$318,302,998 of Common Stock
Feb 28, 2023
S-8
Registration
Jan 19, 2023
FWP
6,500,000 Shares of Common Stock
Dec 15, 2022
Proxies
TYPE
HEADLINE
FILED AT
DEFA14A
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 27, 2026
DEF 14A
Form DEF 14A - Other definitive proxy statements
Apr 27, 2026
DEFA14A
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 30, 2025
DEF 14A
Form DEF 14A - Other definitive proxy statements
Apr 29, 2025
DEFA14A
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Jun 4, 2024
DFAN14A
Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material
May 20, 2024
Ownerships
TYPE
HEADLINE
FILED AT
SCHEDULE 13G
SHAH CAPITAL MANAGEMENT (Filed by)
Oct 16, 2026
SCHEDULE 13D/A
SHAH CAPITAL MANAGEMENT (Filed by)
Oct 16, 2026
SCHEDULE 13G
STATE STREET CORP (Filed by)
Aug 7, 2026
4
Rodgers Richard J (Reporting)
Jun 23, 2026
4
King Rachel K. (Reporting)
Jun 23, 2026
4
DOUGLAS RICHARD (Reporting)
Jun 23, 2026
Chronological
TYPE
HEADLINE
FILED AT
Other
TYPE
HEADLINE
FILED AT
LETTER
Form UPLOAD - SEC-generated letter
May 14, 2024
EFFECT
Form EFFECT - Notice of Effectiveness
Jan 10, 2020
CORRESP
Form CORRESP - Correspondence
Jan 7, 2020
LETTER
Form UPLOAD - SEC-generated letter
Jan 6, 2020
LETTER
Form UPLOAD - SEC-generated letter
Jan 6, 2020
CT ORDER
Form CT ORDER - Confidential treatment order
Dec 17, 2018
